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Running title  
Biology of membrane attack. 
 
Summary  
The membrane attack complex (MAC) is the pore-forming toxin of the complement system, a 
relatively early evolutionary acquisition that confers upon complement the capacity to directly kill 
pathogens. The MAC is more than just a bactericidal missile, having the capacity when formed on 
self-cells to initiate a host of cell activation events that can have profound consequences for tissue 
homeostasis in the face of infection or injury.  Although the capacity of complement to directly kill 
pathogens has been recognised for over a century, and the pore-forming killing mechanism for at 
least 50 years, there remains considerable uncertainty regarding precisely how MAC mediates its 
killing and cell activation activities.  A recent burst of new information on MAC structure provides 
context and opportunity to re-assess the ways in which MAC kills bacteria and modulates cell 
functions.  In this brief review we will describe key aspects of MAC evolution, function and structure 
and seek to use the new structural information to better explain how the MAC works. 
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Introduction   
Complement is a critical component of innate immunity and modulator of adaptive immunity, 
particularly important for defence against bacterial infections and the efficient removal of debris. 
These physiological functions of complement are mediated by a number of products, fragments and 
complexes generated during activation. Larger fragments of the abundant complement proteins C3 
and C4 coat pathogen surfaces to mark them for phagocytic clearance, while smaller fragments of 
these proteins (and of C5) recruit the phagocytes to the site of injury, activating them for enhanced 
bacterial killing. Activation of the complement terminal pathway initiates the assembly on bacteria 
and other targets of the multi-component membrane attack complex (MAC) [1,2]. MAC assembles 
from its components in membranes to create a transmembrane pore that causes prompt osmotic 
lysis of metabolically inert targets such as aged erythrocytes. Water and ions drawn into the target 
through the pore cause swelling and eventual lysis. Nucleated cells targeted by MAC resist lytic 
killing by virtue of multiple layers of defence; however, MAC can have profound effects on nucleated 
cell functions that likely contribute both to homeostasis and pathology [3,4].  
Recent structural studies of the MAC and its precursors have provided some surprises, revealing 
structural features that might help explain how the MAC forms and how it has different effects on 
different targets [5-7].  In this brief review we will provide some historical and phylogenetic 
background to introduce the MAC as an ancient and important component of immune defence; we 
will then introduce the new insights into MAC structure and speculate on how the improved 
understanding of structure might explain aspects of MAC function that have hitherto escaped 
explanation. 
 
Historical perspective 
The very earliest reports of the plasma activity that became known as complement described a heat-
labile plasma component that could cause lysis of target bacteria or erythrocytes – so from a 
functional perspective, the MAC has been recognised since the 19th century! Early theories around 
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complement lysis suggested that the activity was a detergent-like property of complement, 
dissolving the membranes of targets [8].  It was therefore something of a surprise when electron 
microscopy of complement-lysed erythrocytes revealed the presence of numerous ring lesions 
creating pores in the membranes [9,10]. These images, together with a growing body of biochemical 
evidence, led to the recognition that the MAC was a protein-lined transmembrane pore made up of 
the five terminal complement proteins C5b, C6, C7, C8 and C9 [2,11]. 
The availability of pure proteins and depleted sera allowed more definitive structure-function 
studies. It was shown that C5b, still attached to the convertase, binds C6 followed by C7; the tri-
molecular C5b-7 complex is released and becomes associated with adjacent membrane [1,11]. C8 
and then C9 are recruited to complete the lesion which contained one molecule each of C5b, C6, C7, 
C8 and several C9 molecules, the precise number varying between studies [11,12].  Despite this 
biochemical clarity and the microscopy evidence, a debate continued as to whether the MAC was 
truly a rigid, protein-lined pore or a lipid-disrupting leaky patch generator [13].  The demonstration 
that purified C9 could be induced to polymerise in vitro to form a fluid-phase pore-like structure 
resembling the MAC went some way towards resolving the debate, strongly supporting the 
champions of the rigid pore [14,15].  Recent structural studies have brought a degree of clarity as 
well as rasing further questions; these are described in a later section after we look back at the 
evolution of the MAC.  
 
Phylogeny of complement membrane attack  
Complement is an ancient immune defence system but membrane attack is, comparatively, a more 
recent innovation. Invertebrates express a complement system capable of recognition (lectin-like) 
and opsonisation (alternative pathway-like) of pathogens [16]. The phylogenetically earliest 
suggestion of a complement terminal pathway is the demonstration that the genome of the ascidian 
(sea squirt) Ciona intestinalis encodes C6-like molecules with the prototypical MAC/perforin 
(MACPF) domain; demonstration of lytic function of these molecules is lacking [17].  In teleosts 
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(most fish species), multiple terminal complement proteins are present in the genome and 
expressed; for example, rainbow trout express at least C6, C7 (duplicatedͿ, Cϴβ, Cϴγ aŶd Cϵ [18], and 
trout serum forms MAC-like lytic lesions in targets [19]. Nurse shark complement also generates 
obvious pores in targets and the shark membrane attack pathway has been explored. Shark MAC 
comprises at least C5b-like, C8-like and C9-like molecules; the latter two can substitute for human C8 
and C9 for lysis of human C5b-7-coated targets [20].   
The order in which the multiple homologous proteins that comprise the human MAC have emerged 
has been the subject of debate. One side contended that C9 came first, evolving out of a common 
C9/perforin precursor with the terminal pathway components arising from this by gene 
reduplication [21]; a complication here is that C9 is the simplest of the terminal pathway 
components, requiring Cϴα, Cϴβ, Cϳ aŶd Cϲ to aĐƋuiƌe ŵodules as theǇ eǀolǀed. The otheƌ side 
suggested that the more complex C6 and/or C7 evolved first, with gene reduplication and loss of 
domains generating the later components [22]. Phylogenetic analyses across species support the 
latter contention.  Whether C6/C7 alone in these early terminal pathways were capable of 
generating a lytic lesion is unclear, although it is difficult to conceive of any alternative role for these 
pƌiŵitiǀe ͞MAC͟ proteins. The reasons for the evolution of increased complexity in MAC design are 
also uncertain – does the addition of more components increase MAC efficiency of killing? Does it 
enable regulation on self-cells? These questions may be addressed by better understanding of MAC 
structure. 
 
Regulating the MAC 
The MAC, a pore-forming toxin, represents a threat not only to pathogens but also to self-cells. A 
number of defence strategies have evolved to limit terminal pathway activation on host cells and 
protect against MAC-mediated damage. MAC distribution is restricted to the immediate vicinity of 
the forming convertase because the membrane binding site in the C5b-7 intermediate is extremely 
labile and prone to be masked by binding chaperones clusterin or S protein (or indeed, C8 while in 
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the fluid phase); hence, relatively few C5b-7 attach to the membrane to seed MAC formation [4,23]. 
The second line of defence on host cells is CD59, a broadly expressed glycolipid-anchored inhibitor of 
MAC assembly; CD59 locks into the C5b-8 complex and prevents recruitment of C9 – and hence, 
MAC formation [24]. The final defence for MAC that escape CD59 surveillance involves active 
recovery processes that efficiently remove MAC from the membrane [25]; signalling of these 
processes will be discussed below.  
CD59 is a member of the Ly6/uPAR superfamily of GPI-anchored, cysteine-rich proteins that share a 
conserved disulfide bond pattern that defines the three-fingered Ly6/uPAR domain [26]. It is 
ubiquitous in mammals, broadly expressed and functional in MAC inhibition in all mammals tested 
[27-30]. “tƌuĐtuƌal ͞hoŵologues͟ of CDϱϵ haǀe ďeeŶ desĐƌiďed iŶ diǀeƌse speĐies, iŶĐludiŶg 
cyclostome and teleost fish and flatworms [31-34]. The Zebrafish CD59 homologue was reported to 
have bacterial binding and growth inhibition properties [35]; however, evidence of MAC-inhibitory 
function is lacking.  
CD59 binding into the forming MAC raises several interesting structure-function questions. CD59 
does not bind to C5b-7 but binds tightly to C5b-8 and also to C5b-8 complexes that have bound a 
first C9 [24], suggesting that binding sites exist in both C8 and C9. Once bound, CD59 hinders further 
C9 recruitment. The sites on CD59 that mediate MAC inhibition have been identified by mutagenesis 
and map to a surface-exposed hydrophobic groove in the CD59 crystal structure [36]. Homologous 
sites in C8 and C9 have been implicated in binding CD59 [37,38]; as CD59 does not bind either 
native C8 or C9, it is likely that these sites are exposed only during MAC formation. No structure for 
CD59 in complex with a MAC precursor has been described and is now overdue.    
 
The structure of the MAC 
Defining the MAC.  In this review we use the term MAC to refer to the complete membrane-
associated complex comprising C5b, C6, C7, C8 and multiple copies of C9. Although various functions 
haǀe ďeeŶ asĐƌiďed to ͞iŶĐoŵplete͟ MAC precursors comprising C5b6, C5b67 or C5b678, evidence 
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that they do anything to a target is sketchy and mechanism lacking.  Further, in the in vivo context 
where all terminal components are present and in excess, ͞iŶĐoŵplete͟ precursor complexes will 
rapidly progress to completion. Hence, although the precursors are essential intermediates in MAC 
formation, only the complete MAC is of biological relevance.   
Evolving complexity of MAC structure.  Imaging studies in the 1960s established the concept of the 
MAC as a doughnut-like protein-lined pore in the membrane (Figure 1A) [9-11]. The exact 
composition of the doughnut was hotly debated, some contending that size dictated that it must be 
a (C5b-9)2 dimer [39], while others suggested that the pore grew by recruiting more C9 [40]. The 
demonstration in the 1980s that purified C9 self-polymerised when incubated for prolonged periods 
at 370C was a major step in resolving the debate [14,15]. Electron microscopy (EM) revealed that 
these polymers (poly-C9) were ring structures with dimensions and architecture closely resembling 
the MAC (Figure 1C). Biophysical analyses showed that the poly-C9 complex comprised between 12 
and 18 C9 monomers in a closed ring.  These findings strongly supported a model of the MAC where 
the bulk of the ring was formed by (poly) C9 with the other components either forming a minor part 
of the ring or even excluded to the periphery. This model gained general acceptance and stood for 
thirty years.  
Structures of individual MAC components. The publication of a crystal structure for C8 in 2011 
represented the first detailed structure of an intact MAC component and a first picture of how C8 
and C9 might assemble into the MAC pore [41].   Crystal structures of C6 and the C5b6 complex 
provided insight into the first steps of MAC assembly [42,43,5].  Docking the C5b6 crystal structure 
into an electron cryo-microscopy structure of the soluble sC5b-9 complex added further clarity on 
direction of assembly of the MAC components [5]. 
Electron cryo-microscopy adds detail and complexity.  Technical advances in imaging over the last 
thirty years have made possible much greater resolution for complex structures, encouraging us and 
others to re-address the structure of the MAC in order to better understand its function. Using 
highly purified terminal pathway components in a reactive lysis system, we generated MAC on 
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liposoŵes iŶ the aďseŶĐe of ͞Ŷoise͟ fƌoŵ other proteins [6]. The formed MAC were detergent-
extracted, polished by density gradient centrifugation and imaged by electron cryo-microscopy 
(cryo-EM) (Figure 1D). Multiple images of MAC particles in various orientations were captured and 
averaged to obtain a model that was refined to a final resolution of 8.5 Å (Figure 1E).  At first glance 
the structure obtained, a regular cylinder with a single stalk, closely resembled that described thirty 
years earlier; however, as more detail emerged, so did several novel features (Figure 2).  First, it was 
Đleaƌ that the ĐǇliŶdeƌ ǁas hoŵogeŶeous ǁith ƌegaƌd to Ŷuŵďeƌs of pƌoteiŶ ͞staǀes͟, ϮϮ iŶ total 
ĐoŵpƌisiŶg oŶe staǀe eaĐh fƌoŵ Cϲ, Cϳ, Cϴβ aŶd Cϴα aŶd ϭϴ staǀes fƌoŵ iŶdiǀidual Đopies of Cϵ. 
Second, the first fouƌ staǀes, pƌoǀided ďǇ Cϲ, Cϳ, Cϴβ aŶd Cϴα ǁeƌe asǇŵŵetƌiĐ, oƌieŶted diffeƌeŶtlǇ 
to the 18 C9 staves and too short to fully penetrate the membrane. Third, the structure was not a 
closed cylinder – the final C9 was not fixed back to the initial C6, giving a ͞split-ǁasheƌ͟ appeaƌaŶĐe 
to the cylinder and providing a way in which the diameter of the cylinder pore could vary. The 
͞pitĐh͟ of the foƌŵiŶg ĐǇliŶder was set by reorientation and alignment of the CDC/MACPF domains 
of Cϲ, Cϳ, Cϴβ aŶd Cϴα, aŶd this, togetheƌ ǁith a ƌeoƌieŶtatioŶ of Cϴγ oŶ the iŶŶeƌ ƌiŵ of the pore, 
eǆposed ďiŶdiŶg sites oŶ Cϴα foƌ the fiƌst Cϵ.  
The role of the lipocalin-like ŵoleĐule Cϴγ iŶ MAC asseŵďlǇ has loŶg ďeeŶ a ŵǇsteƌǇ [44].  Cϴγ is 
disulphide-liŶked to Cϴα aŶd the Đoŵpleǆ is non-ĐoǀaleŶtlǇ assoĐiated ǁith Cϴβ, a relationship that 
is conserved in all species where C8 subunit structure has been studied. It ǁas kŶoǁŶ that Cϴγ ǁas 
Ŷot esseŶtial foƌ MAC foƌŵatioŶ; iŶdeed, ǁheŶ Cϴαγ ǁas ďioĐheŵiĐallǇ stƌipped of the γ-subunit, 
Cϴα readilǇ ďouŶd Cϴβ aŶd the resultant complex was capable of forming a hemolytic MAC [45]. 
Structures of the soluble C8 heterotrimer and C8αMACPF/C8Ȗ complex [41,46], together with 
analysis of C8Ȗ within the context of the MAC [6] provide some clues as to its role. In each structure, 
C8Ȗ is disulphide linked to the same hairpin extension from the MACPF domain of C8α, in agreement 
with previous biochemical evidence [47]. However, this hairpin rotates with respect to the core 
MACPF domain of C8α and adopts a different orientation in each of the three complexes. In the 
absence of C8ȕ, the crystal structure traps an extended conformation of C8Ȗ, while the intact 
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heterotrimer shows C8Ȗ curled back on the otherwise exposed C9-binding interface on C8αMACPF. 
This is consistent with biochemical experiments that showed in the absence of C8ȕ, the C8αȖ complex 
can reversibly bind C9 [48]. While these crystal structures may trap snapshots along a continuum of 
C8Ȗ orientations, it remains plausible that the presence of C8ȕ may restrict mobility of the hairpin. 
Furthermore, the published MAC stƌuĐtuƌe shoǁs that Cϴγ pƌojeĐts iŶto the luŵeŶ of the β-barrel 
and is displaced from its position in the soluble C8 crystal structure [6]. Upon MAC formation, 
CϴαMACPF ƌotates to aligŶ the Đoƌe β-sheets ǁith CϴβMACPF peƌŵitting recruitment of C9. Based 
oŶ these stƌuĐtuƌal data, the ƌole of Cϴγ ǁould thus appeaƌ to ďe to prevent C8-C9 interactions other 
than in the forming MAC.  
Cryo-electron tomography supports a new MAC model.  Another imaging approach to defining 
MAC structure has recently been published using phase-plate cryo-electron tomography, a method 
designed to improve contrast in electron microscopy images [7].  MAC lesions were formed on lipid 
bilayers, either through classical pathway activation or by reactive lysis using purified proteins and 
imaged in situ in the membrane. Tomograms were reconstructed from multiple images and models 
fitted using known structures. MAC lesions generated in this manner were heterogeneous in 
ĐoŵpaƌisoŶ ǁith the ͞eǆtƌaĐted͟ MAC described above; more than half of the observed lesions were 
single ring structures with a single C5b-8 stalk, closely resembling the extracted MAC structure but a 
minority of lesions appeared to be aggregates containing several C5b-8 stalks in various 
configurations. Averaging of selected single ring lesions and fitting of known component structures 
yielded a ring structure (23 Å resolution) with a stalk derived from C5b6 and a ring diameter that is 
consistent with a 22-component complex, ǁith oŶe ͞staǀe͟ eaĐh fƌoŵ Cϲ, Cϳ, Cϴβ aŶd Cϴα aŶd the 
rest from C9. Despite being the same diameter as the detergent extracted MAC, only 16 C9 units are 
modelled in this structure. This may be a result of unresolved density at the lower resolution ring 
seam, or indeed may indicate a level of heterogeneity in the composition of the MAC. The ring was 
incomplete, a split washer, and the precursor complex staves did not traverse the membrane, 
precisely as described for the extracted MAC.  
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The similarities between these structures, derived independently and in different ways, is 
remarkable and gives confidence that they represent the complete MAC; the differences relate 
predominantly to heterogeneity and an apparent predilection for precursor complexes to associate 
and aggregate in the membrane.  
Poly-C9 structures reveal similarities and important differences. Yet more evidence supporting the 
22-fold composition of the MAC pore is provided by a new structure of poly-C9 [49].  Whereas 
earlier analyses based on low resolution EM and biochemical studies had suggested that the poly-C9 
ring was composed of between 12 and 18 C9 molecules [50], the new cryo-EM structure at 8 Å 
resolution clearly demonstrate that poly-C9 is assembled from 22 C9 monomers in a closed ring. The 
closed ring structure illustrates an important difference to the MAC – in poly-C9 the final C9 can 
intercalate with the first to complete the ring, while in the MAC the final C9 cannot form a stable link 
with the initiating C6. The poly-C9 structure demonstrates an important contribution of the 
thrombospondin-1 (TSP1) domains to C9-C9 oligomerisation.  
 
Emergence of a consensus structure. The deluge of structural information provides both clarity and 
clues to the process of MAC formation and the structure of the complete MAC. The structures 
confirm the order and clockwise direction of assembly from precursors through to pore as proposed 
in structures extrapolated from the soluble C5b-9 complex [5]. They demonstrate that the obvious 
stalk protrusion is predominantly C5b-derived. They unequivocally define the stoichiometry of the 
complex and show that this is dictated by the rotation of precursors to an orientation that sets the 
͞pitĐh͟ of the foƌŵiŶg poƌe.  They identify interaction interfaces that are key to the MAC sequential 
assembly mechanism.  Surprisingly, the physiological pore is not a symmetric ring as modelled in 
previous structures referenced above, but rather has a unique split-washer configuration, which 
likely impacts biophysical properties of its lipid environment.   
All three newly resolved MAC/polyC9 structures are consistent with the MAC forming a giant β-
barrel pore. All components, except C5b, contain a central MACPF/CDC fold, found in a number of 
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pore-forming proteins such as the cholesterol-sensing bacterial toxins [51]. A series of biochemical 
studies on members of the CDC family have shed light on how this domain facilitates pore formation. 
The MAC/CDC domain is formed of a central 4-stƌaŶded kiŶked β-sheet, conferring an ͚L͛ shape to 
the domain, flanked by a series of 3 helical bundles that are critical to membrane insertion. During 
pore formation, transmembrane segments (TMS) 1 and 2 undergo a large conformational 
ƌeaƌƌaŶgeŵeŶt to foƌŵ β-hairpins [52]. These hairpins insert into the lipid bilayer, forming the wall 
of the β-pore. A third helical bundle (CH3) appears to aĐt as a ͚latĐh͛, sǁiŶgiŶg toǁaƌds the ĐeŶteƌ of 
the pore lumen and triggering TMS unfurling [53,54]. The presence of this highly conserved 
MACPF/CDC fold within the terminal complement proteins forming the MAC suggests a similar 
mechanism of pore formation, supported by mutational data and contiguous barrel density 
observed in the recent EM structural studies [6,7].  This structural model of pore formation is 
supported by the deŵoŶstƌatioŶ that tƌaŶsŵeŵďƌaŶe segŵeŶt sǁaps ďetǁeeŶ Cϴα oƌ Cϵ aŶd 
perfringolysin yielded hybrids that were capable of lytic pore formation [55].  
 
The stages of MAC assembly 
A synthesis of the available structures provides insight into how the MAC is initiated. Cleavage of C5 
causes major conformational change in C5b, creating a labile conformation that rapidly decays 
unless stabilised by C6 binding through its short consensus repeat/complement control protein 
(SCR/CCP) and factor I/membrane attack complex (FIMAC)-like domains. Rotation of the C6 molecule 
aŶd opeŶiŶg up of its ĐeŶtƌal β-sheet reveals binding sites for C7; the SCR/CCP and FIMAC domains 
of C7 likely bind into the C5 macroglobulin domains, thereby displacing the C5b67 complex from the 
convertase [5].  The C5b67 complex possesses a poorly defined hydrophobic site enabling complexes 
that encounter membrane before the site decays or is captured by fluid-phase inhibitors to bind 
membrane. Recent cryo-EM tomography images of membrane-bound C5b67 suggest that the 
complex is buried in the outer lamella of the membrane [7]. Once bound to a membrane, C5b67 is 
stable and ready to accept C8.  The stability of C5b67 is apparent from studies of erythrocyte 
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intermediates; whereas C5b6 binds weakly and is removed by washing, C5b-7 binds tightly, surviving 
multiple wash steps and prolonged storage, without impairing the integrity of the membrane. 
Binding of C5b67 does not cause leakage through the membrane, supporting the imaging evidence 
that it disrupts only the outer lamella [7]. C8β ďiŶds Cϳ iŶ the tri-ŵoleĐulaƌ Đoŵpleǆ, ďoth Cϴβ aŶd 
Cϴα uŶfold, uŶǁiŶd aŶd aligŶ ǁith Cϳ, the TM“ϭ/TM“Ϯ doŵaiŶs iŶseƌtiŶg deep iŶto the ďilaǇeƌ, likely 
disrupting but not fully penetrating the inner lamella.  Imaging and some functional studies suggest 
that the membrane is breached at this stage; however, this is likely dependent on the lipid 
composition of the membrane and of minor functional consequence in comparison to the MAC pore. 
‘otatioŶ of the Cϴα ĐhaiŶ aŶd displaĐeŵeŶt of Cϴγ eǆposes the binding site for the first C9 as noted 
above. C9 binds, unfolds and inserts, facilitated by the membrane disruption caused by C5b-8 which 
lowers the activation energy for C9 binding and insertion [56,57]. Further acquisition of C9 molecules 
into the complex is then energetically favoured leading to rapid completion of the pore. 
 
The importance of the asymmetric pore 
We contend that the most important difference between the newly described MAC structures and 
previous models (and from the structure of poly-C9) is the observed asymmetry, a consequence of 
its heterogeneous molecular composition with contributions from each of the five terminal 
compoŶeŶts ;Cϲ, Cϳ, Cϴβ, Cϴα, C9). The -hairpins of the terminal components comprising the C5b-8 
precursor are shorter than those of C9 and hence fail to completely breach the membrane but 
nevertheless cause disruption of both the outer and inner lamellae of the lipid bilayer. By analogy to 
the lipid-binding residues of cholesterol-dependent bacterial pore-forming cytolysins, we suggest 
that these partially inserted C5b-ϴ β-hairpins may confer a degree of lipid selectivity to MAC 
formation.  The concept that MAC preferentially targets certain membrane domains in nucleated 
cells is an old one linked to the well-documented recovery process of MAC removal [25].  Similarly, 
MAC targeting to specific lipid environments in the bacterial cell membrane has been suggested to 
facilitate bacterial killing [58-60].    
13 
 
 
The second component of asymmetry is the split-washer appearance seen in both the cryo-EM and 
cryo-tomography structures; this confers an unanticipated degree of flexibility to the pore which is 
imaged in various degrees of closure. Within the context of a membrane, terminal pathway proteins 
can form pores with varied stoichiometries [7]. The biological implications of this heterogeneity 
merits further investigation and may be influenced by the local lipid environment of the target 
membrane.   
Cryo-tomography images of membranes bearing precursor C5b67 or C5b-8 complexes, and even 
intact MAC, showed different-sized aggregates of the complexes. Whether MAC/MAC precursor 
aggregation is of biological relevance is uncertain; however, images of nucleated cells exposed to 
MAC show obvious aggregation of MAC into tightly packed clusters for elimination from the cell 
during recovery [25].   
 
Structures inform bacterial killing by MAC 
The single essential role of the MAC in immune defence is to kill a subset of gram-negative bacteria, 
cocci of the phyla Neisseria, Moraxella and Haemophilus, that are inefficiently eliminated by 
opsonophagocytosis [61-63]. Of these, protection against Neisseria is of most clinical relevance as is 
apparent from the fact that terminal pathway component deficiencies most commonly present with 
meningitis and/or septicaemia caused by N. meningitidis [61].  The Neisserial cell wall, comprising 
two lipid membranes separated by a layer of peptidoglycan, represents a particular challenge for a 
pore-forming toxin; how are the outer barriers breached to deliver the lethal hit to the inner 
membrane?  A variety of mechanisms have been suggested, including targeting of MAC formation to 
areas of adhesion between inner and outer membranes [62], and delivery of terminal complement 
proteins into the periplasmic space through the MAC pore with subsequent MAC assembly on the 
inner membrane [63,64].  The first proposed mechanism can be effectively dismissed when 
considered in light of the MAC structure [65]; the transmembrane region of the MAC is located at 
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the extreme end of the barrel, with no space for a second insertion site! The second hypothesis 
requires that C5b6 and each of the terminal components can pass through the MAC pore. This is 
unlikely given a pore size of ~10nm, too small for many of the MAC proteins, though the pore size 
does not preclude transport of lysozyme. A third model, based on recent structural data for the MAC 
[6], suggests a role for local membrane distortion in bacterial killing.  
 
Structures inform cell response to MAC 
The classical view of the MAC is that of a rigid pore penetrating the membrane through which water 
and ions transit unhindered into the cell to cause lysis; however, it has long been clear that the 
situation is much more complex, particularly when MAC is activated on nucleated cell targets or on 
bacteria. Nucleated cells express multiple resistance mechanisms to avoid MAC-mediated killing but 
respond to MAC in a variety of ways, including the rapid removal of MAC lesions from the cell 
surface, a process termed recovery [3,4,25].  Imaging of MAC-exposed cells and shed membrane 
vesicles shows that MAC lesions are aggregated into densely packed clusters on the cell and vesicle 
membrane; precisely how these aggregates form within minutes of attack has been a puzzle. The 
structures indicate a tendency for MAC precursors to aggregate which might contribute to the 
observed clustering; however, no such efficient clustering is seen on inert targets such as 
erythrocytes. The suggestion that MAC pore asymmetry confers selectivity for specific lipid 
microdomains raises the possibility that MAC selectively deposit en masse and at high density in 
these microdomains. Indeed, it has been shown that shed MAC-decorated vesicles differ in protein 
and lipid content from bulk membrane in [66,67], and a recent analysis of microvesicles released 
from tumor cells in response to MAC showed that they were enriched in lipid raft markers and GPI-
anchored proteins [68]. If a tendency to aggregate and to deposit in lipid raft microdomains explains 
the clustering, what then explains the efficient elimination from the membrane? Again, the 
structures suggest an answer; the lipid perturbation induced by pore asymmetry is likely most 
marked at the edges of MAC clusters, destabilising the membrane and leading to shedding or 
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internalisation. A final puzzle related to recovery concerns the shed MAC-decorated vesicles – 
despite the aďuŶdaŶĐe of MAC lesioŶs theǇ doŶ͛t leak eŶtƌapped dǇe [4,23]! Others have 
suggested that the poƌe is ͞plugged͟ iŶ soŵe ŵaŶŶeƌ [69]. The recent structures allow us to 
speculatively suggest a mechanism foƌ poƌe ͞pluggiŶg͟ involving loops of C9 that in the poly C9 
structure are modelled as folded back on the transmembrane regions, spanning approximately 50 Å. 
If these loops are reoriented to lay flat across the missing membrane of shed vesicles they could 
span the entire diameter of the MAC pore (110 Å).      
 
MAC formation on nucleated cells has been associated with many and diverse effects in different cell 
types, including altered proliferation, induction/inhibition of apoptosis, changes in cell motility, 
inflammasome activation and release of inflammatory mediators etc. [70-73] (Figure 3).  The many 
pro-inflammatory effects have established the MAC as an important driver of inflammation; 
however, the signalling pathways involved remain undefined. In all cells studied, calcium signalling 
plays a part; calcium ion influx through the MAC pore causes a rapid increase in intracellular free 
calcium ([Ca2+]i) from nanomolar to micromolar levels [25]. Changes in [Ca2+]i impact calcium-sensing 
signalling systems such as calmodulin to initiate a cascade of downstream effectors, including 
activation of the core signal hubs AKT and PI3K [74]. These pathways have been implicated in cell 
responses to MAC in diverse cell types [75,76], and were again highlighted in an unbiased 
transcriptomics analysis of MAC-triggered signalling pathways [77]. It is, however, clear that calcium 
is not the only mediator of MAC signals; removal of extracellular calcium by chelation reduced but 
did not ablate MAC-induced cell activation [25]. Indeed, a rise in [Ca2+]i still occurred, demonstrating 
MAC-triggered calcium store release. The key trigger for endoplasmic reticulum (ER) calcium store 
release is inositol 1,4,5-triphosphate (IP3), usually generated at the membrane when a G-protein 
coupled receptor (GPCR) binds its extracellular ligand; associated G-proteins then activate 
phospholipase C (PLC) causing release of IP3 into the cytoplasm. It has been reported that both MAC 
precursors and the MAC associate with G-proteins in the membrane that confer signalling capacity 
16 
 
to the complex.  Immunoprecipitates of MAC from attacked cells contained all the component 
subunits of a pertussis toxin (PTX)-sensitive G protein complex; this finding was given functional 
significance by demonstrating that PTX inhibited MAC effects on the cell [78,79].  Perhaps the most 
likely explanation of the reported association with MAC is that the MAC immunoprecipitates contain 
GPCR and their associated G-proteins.  Although there has been no demonstration of direct 
interaction between MAC and GPCR, it is well known that GPCR localise preferentially to lipid rafts 
[80], sites of MAC accumulation and multi-functional membrane signalling platforms that sequester 
numerous receptors and signallers, including GPCRs and GPI-linked proteins. A recent publication 
suggested that MAC may also signal in intracellular locations; after internalisation and incorporation 
into Rab5+ endosomes MAC activated non-canonical pathways for NF-kB activation [81]. The 
cumulative data suggest that MAC signalling requires its location in specialised microenvironments – 
notably, the signalling-rich lipid raft environment; structural features described above may shed light 
on why and how MAC prefers such environments and how it interacts (directly or indirectly) with 
signalling molecules.  
 
Concluding remarks 
We here present the MAC as an ancient and critical part of innate immunity that has evolved 
considerable structural complexity. This evolution from a simple pore to a highly ordered 
asymmetric oligomer has conferred additional properties such as lipid selectivity and pore flexibility 
that enable MAC to interact with self-cell protection mechanisms and influence cell function in 
multiple ways. The pressure to evolve may have come from bacteria that presented membranes 
difficult to penetrate with a simple pore. The resultant complex is an elegant biological machine that 
goes far beyond its popular image as a simple pore. 
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Figure Legends 
Figure 1 Visualising the MAC over the last 3 decades. (A-C) Early negatively-stained electron 
micrographs of both the MAC and poly-C9. (A) MAC complexes assembled on rabbit erythrocytes 
(from reference # 40). (B) Side-view of the MAC inserted into liposomes (from reference # 14). (C) 
Poly-C9 complexes showing both top and side views (from reference # 12). (D-E) Recent images of 
the MAC enabled by advanced in both EM hardware and software. (D) Cryo-EM image of detergent-
solubilised MAC complexes. Scale bar, 50 nm. (E) Representative 2D class averages of both a top and 
side view of the detergent-solubilised MAC.  
 
Figure 2 Comparison of the recent structural insights in both the MAC and poly C9. (A) Cryo-EM 
ƌeĐoŶstƌuĐtioŶ of the Đoŵplete, deteƌgeŶt soluďilised MAC, highlightiŶg the ͚split-ǁasheƌ͛ shape aŶd 
22 subunit composition (EMDB: 3134; Reference #6). Components coloured as follows: C5b (purple), 
Cϲ ;ǇelloǁͿ, Cϳ ;gƌeeŶͿ, Cϴβ ;oƌaŶgeͿ, Cϴα ;ƌedͿ, Cϴγ ;daƌk ďlueͿ, Cϵ ;light ďlueͿ. The transmembrane 
β-hairpins forming the wall of the pore are coloured in grey, and includes the detergent belt. (B) 
Cryo-EM reconstruction of the poly-C9 complexes formed in the absence of membranes or 
detergent (EMDB: 3235; Reference #49). The 22 subunits of the map are segmented, individually 
coloured and fitted with a pseudo atomic model (PDB:5FMW). (C) Cryo-tomography reconstruction 
of the complete MAC formed on liposomes (EMDB: 3289; Reference #7). The MAC is in teal, the 
bilayer in grey. All figures are rendered in Chimera [82]. 
 
Figure 3 Schematic of the signalling cascades associated with sub-lytic MAC. Pore components are 
coloured as in Fig.2A. 
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